Loading the company…
Loading the company…
In the last ten years FDA made 5 decisions for Vascutek (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2017 (2). The latest was on 2025-02-27.
| Family | Decisions on record |
|---|---|
| Dialysis access | 22 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-02-27 | 510(k) | K241550 | Gelweave Vascular Prostheses |
| 2024-11-15 | 510(k) | K241070 | Gelsoft Plus Vascular Prostheses |
| 2021-04-06 | 510(k) | K202703 | Vascutek Gelsoft Plus ERS Vascular Graft |
| 2017-07-14 | 510(k) | K162803 | Gelseal Vascular Grafts, Gelsoft Vascular Grafts, Gelsoft Plus Vascular Grafts |
| 2017-06-30 | 510(k) |
| K162794 |
| Gelweave Vascular Grafts |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Vascutek.